Minimally Invasive Biopsy Techniques Market, By Product Offered (Tests, Kits & Consumables, and Instruments), By Technique, By Circulating Biomarker, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4175
|
Published Date
July 2025
|
Pages
393
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Minimally Invasive Biopsy Techniques Market size was valued at US$ 13,146.12 Million in 2024, expanding at a CAGR of 10.5% from 2025 to 2032.
Minimally invasive biopsy techniques involve obtaining tissue samples for diagnostic purposes through small incisions, causing less damage to surrounding tissues compared to traditional surgical biopsies. These methods offer several advantages, including reduced scarring, faster recovery times, and a lower risk of complications. Commonly used techniques include fine-needle aspiration (FNA), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB), which are often guided by imaging technologies such as ultrasound, MRI, or mammography. Overall, minimally invasive biopsy techniques represent a major advancement in tissue sampling by providing accurate diagnoses while minimizing patient discomfort and recovery time.
Minimally Invasive Biopsy Techniques Market- Market Dynamics
The rising global incidence of cancer, combined with the growing importance of precision diagnostics, is expected to drive market growth.
As the global incidence of cancer continues to rise, there is an urgent need for early, accurate, and less invasive diagnostic methods. Minimally invasive biopsy techniques—such as fine-needle aspiration, core needle biopsy, and liquid biopsy—offer faster recovery times, reduced patient discomfort, and lower complication rates compared to traditional surgical methods. According to the World Health Organization, new cancer cases are projected to reach 35 million by 2050, representing a 77% increase from the 20 million cases reported in 2022. Meanwhile, growing investments in oncology research, personalized medicine, and healthcare innovation present significant opportunities for market growth. However, the high costs associated with advanced biopsy technologies may pose challenges to market expansion.
Minimally Invasive Biopsy Techniques Market- Segmentation Analysis:
The Global Minimally Invasive Biopsy Techniques Market is segmented based on Product Offered, Technique, Circulating Biomarker, Application, End User, and Region.
The minimally invasive biopsy techniques market is segmented based on products offered into Tests, Kits & Consumables, and Instruments, with Kits & Consumables holding a leading position. This dominance is due to the frequent, disposable nature of these products and their critical role in maintaining sterile, accurate diagnostic procedures. Items such as biopsy needles, forceps, syringes, reagents, and sample collection containers are essential for various biopsy methods, including fine-needle aspiration, core needle biopsy, and vacuum-assisted biopsy. The consistent demand for these consumables in hospitals, diagnostic laboratories, and outpatient centers significantly drives market growth. Globally, governments are recognizing the importance of reliable diagnostic consumables; for example, the European Commission’s In Vitro Diagnostic Regulation (IVDR) mandates stringent quality and safety standards for biopsy consumables, ensuring patient safety and supporting market expansion across member countries.
When categorized by technique, the market includes Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, and others, with Liquid Biopsy leading growth. Liquid biopsy’s appeal lies in its ability to detect cancer-related biomarkers via a simple blood draw, offering a safer, faster, and more patient-friendly alternative to traditional tissue biopsies. It enables real-time disease monitoring, early cancer detection, and treatment response evaluation without invasive procedures. The surge in precision medicine and demand for early diagnostics accelerates the adoption of liquid biopsy in clinical settings worldwide. Reflecting this trend, government health agencies like the U.S. Food and Drug Administration (FDA) have approved several liquid biopsy tests, while national cancer programs in countries such as Canada and Australia are integrating liquid biopsy into screening and monitoring protocols to improve cancer outcomes.
The market also segments circulating biomarkers into Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, and others, with cfDNA driving significant growth. cfDNA plays a pivotal role in non-invasive cancer diagnostics by analyzing DNA fragments shed by tumors into the bloodstream. This enables the detection of genetic mutations, tumor burden, and resistance to therapy, providing real-time insights into tumor dynamics without surgery. Governments globally are investing in cfDNA research and clinical application; for instance, the National Cancer Institute (NCI) in the U.S. funds extensive cfDNA studies aimed at enhancing precision oncology, while European countries are establishing cfDNA-based testing in public health frameworks to facilitate early cancer detection.
In terms of application, the market is divided into Clinical and Therapeutic sectors, with clinical applications leading growth. The increased adoption of minimally invasive biopsy techniques for routine diagnostics and disease monitoring propels this expansion. Hospitals, diagnostic labs, and specialty clinics are progressively utilizing techniques like liquid biopsy, fine-needle aspiration, and image-guided biopsies for early cancer detection and personalized treatment planning. Globally, health ministries emphasize the clinical integration of these methods; the World Health Organization (WHO) has advocated for minimally invasive diagnostics as part of its global cancer control strategy, encouraging countries to incorporate such technologies into national screening and monitoring programs.
Finally, by end-user, the market is categorized into Hospitals & Clinics, Academic & Research Institutions, and Ambulatory Care Centers, with hospitals and clinics at the forefront due to their high patient volumes, advanced diagnostics, and medical expertise. These facilities serve as primary care points for disease detection, especially in oncology, where procedures like fine-needle aspiration, core needle biopsy, and liquid biopsy are routine. Academic and research institutions contribute by advancing biopsy techniques and biomarker discovery, while ambulatory care centers are gaining traction as outpatient settings favor minimally invasive, cost-effective procedures with quicker patient recovery. Governments worldwide are supporting these trends; for example, the National Health Service (NHS) in the UK has expanded funding for outpatient cancer diagnostic services to increase accessibility and efficiency in minimally invasive biopsies.
Minimally Invasive Biopsy Techniques Market- Geographical Insights
North America leads market growth, driven largely by the increasing adoption of liquid biopsy technologies. The rising cancer incidence, combined with a strong emphasis on early and accurate diagnosis, has accelerated the integration of liquid biopsy into clinical practice. Additionally, the region’s robust presence of leading biotechnology companies, advanced healthcare infrastructure, and supportive regulatory environment have further fueled market expansion. The United States, with a population exceeding 330 million, benefits from one of the most complex healthcare systems in the world, characterized by intricate interactions among providers, payers, and patients. According to the World Bank, global government healthcare expenditure reached approximately USD 8 trillion in 2023, reflecting widespread investments in diagnostic and therapeutic advancements. Europe holds the position of the second-largest market, supported by significant advancements in imaging and navigation technologies, as well as strong governmental support for early cancer detection programs.
Minimally Invasive Biopsy Techniques Market- Competitive Landscape:
The Minimally Invasive Biopsy Techniques market is highly competitive, featuring a diverse range of established medical device manufacturers, diagnostic companies, and emerging biotech startups. Leading players are focused on developing advanced imaging-guided, robotic-assisted, and AI-integrated biopsy solutions that improve accuracy while minimizing procedural risks. Significant investments are also being made in non-invasive liquid biopsy technologies, particularly those targeting circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA), to facilitate real-time cancer monitoring. Additionally, companies are expanding their presence in the Asia-Pacific and Latin American markets to capitalize on the increasing demand for less invasive diagnostic methods.
Recent Developments:
- On January 22, 2025, GRACE Breast Imaging & Medical Spa in Iowa became the first healthcare facility in the United States to install Siemens Healthineers’ Mammomat B.brilliant. This represents the first complete redesign of the mammography platform in over a decade. The Mammomat B.brilliant features advanced 3D image acquisition and reconstruction technology, along with full-field digital mammography capabilities, including two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Becton, Dickinson and Company (BD)
- Danaher Corporation (Leica Biosystems)
- Hologic, Inc.
- Boston Scientific Corporation
- Medtronic plc
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Argon Medical Devices
- Cook Medical
- Fujifilm Holdings Corporation
- Olympus Corporation
- R. Bard (now part of BD)
- Biocept, Inc.
- Guardant Health
- Qiagen N.V.
- Exact Sciences Corporation
- Bio-Rad Laboratories
- Menarini Silicon Biosystems
- NeoGenomics Laboratories
- Others
GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY PRODUCT OFFERED- MARKET ANALYSIS, 2019 - 2032
- Tests
- Kits & Consumables
- Instruments
GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented Lesion Assays
- Others
GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY CIRCULATING BIOMAKER- MARKET ANALYSIS, 2019 - 2032
- Circulating Tumor Cells (CTCs)
- Cell Free DNA (cfDNA)
- Circulating Tumor DNA (ctDNA)
- Extracellular Vesicles
- Others
GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Clinical
- Treatment Monitoring
- Prognosis & Recurrence Monitoring
- Treatment Selection
- Others
- Therapeutic
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Academic & Research Institutions
- Ambulatory Care Centers
GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Minimally Invasive Biopsy Techniques Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Minimally Invasive Biopsy Techniques Market Snippet by Product Offered
2.1.2. Minimally Invasive Biopsy Techniques Market Snippet by Technique
2.1.3. Minimally Invasive Biopsy Techniques Market Snippet by Circulating Biomaker
2.1.4. Minimally Invasive Biopsy Techniques Market Snippet by Application
2.1.5. Minimally Invasive Biopsy Techniques Market Snippet by End User
2.1.6. Minimally Invasive Biopsy Techniques Market Snippet by Country
2.1.7. Minimally Invasive Biopsy Techniques Market Snippet by Region
2.2. Competitive Insights
3. Minimally Invasive Biopsy Techniques Key Market Trends
3.1. Minimally Invasive Biopsy Techniques Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Minimally Invasive Biopsy Techniques Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Minimally Invasive Biopsy Techniques Market Opportunities
3.4. Minimally Invasive Biopsy Techniques Market Future Trends
4. Minimally Invasive Biopsy Techniques Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Minimally Invasive Biopsy Techniques Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Minimally Invasive Biopsy Techniques Market Landscape
6.1. Minimally Invasive Biopsy Techniques Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Minimally Invasive Biopsy Techniques Market – By Product Offered
7.1. Overview
7.1.1. Segment Share Analysis, By Product Offered, 2024 & 2032 (%)
7.1.2. Tests
7.1.3. Kits & Consumables
7.1.4. Instruments
8. Minimally Invasive Biopsy Techniques Market – By Technique
8.1. Overview
8.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
8.1.2. Liquid Biopsy
8.1.3. Optical Biopsy
8.1.4. Brush Biopsy
8.1.5. Pigmented Lesion Assays
8.1.6. Others
9. Minimally Invasive Biopsy Techniques Market – By Circulating Biomaker
9.1. Overview
9.1.1. Segment Share Analysis, By Circulating Biomaker, 2024 & 2032 (%)
9.1.2. Circulating Tumor Cells (CTCs)
9.1.3. Cell Free DNA (cfDNA)
9.1.4. Circulating Tumor DNA (ctDNA)
9.1.5. Extracellular Vesicles
9.1.6. Others
10. Minimally Invasive Biopsy Techniques Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Clinical
10.1.2.1. Treatment Monitoring
10.1.2.2. Prognosis & Recurrence Monitoring
10.1.2.3. Treatment Selection
10.1.2.4. Others
10.1.3. Therapeutic
10.1.3.1. Lung Cancer
10.1.3.2. Breast Cancer
10.1.3.3. Prostate Cancer
10.1.3.4. Colorectal Cancer
10.1.3.5. Others
11. Minimally Invasive Biopsy Techniques Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals & Clinics
11.1.3. Academic & Research Institutions
11.1.4. Ambulatory Care Centers
12. Minimally Invasive Biopsy Techniques Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Minimally Invasive Biopsy Techniques Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Minimally Invasive Biopsy Techniques Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Becton, Dickinson and Company (BD)
13.2.2. Danaher Corporation (Leica Biosystems)
13.2.3. Hologic, Inc.
13.2.4. Boston Scientific Corporation
13.2.5. Medtronic plc
13.2.6. Siemens Healthineers
13.2.7. GE HealthCare
13.2.8. Philips Healthcare
13.2.9. Argon Medical Devices
13.2.10. Cook Medical
13.2.11. Fujifilm Holdings Corporation
13.2.12. Olympus Corporation
13.2.13. R. Bard (now part of BD)
13.2.14. Biocept, Inc.
13.2.15. Guardant Health
13.2.16. Qiagen N.V.
13.2.17. Exact Sciences Corporation
13.2.18. Bio-Rad Laboratories
13.2.19. Menarini Silicon Biosystems
13.2.20. NeoGenomics Laboratories
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
